DBM News


A team of researchers from the Department of Biomedicine (University of Basel) and from University of Geneva led by Daniel Pinschewer have constructed an artificial virus that will target killer T cells specifically to tumors.

Their study, which could lead to novel innovative cancer treatments, was recently published in Nature Communications